BODY IMMUNOLOGICAL REACTIVITY IN OPIOMANIA

Due to the general trend of changes in reactivity in many exogenous and endogenous diseases, more and more attention is currently being paid to changes in immunological reactivity in drug addiction. The expediency of assessing the state of immune mechanisms in opioid addiction is determined by the need to predict their course and outcome. The aim of the study was to study the immunological reactivity of the body in patients with opium addiction in a stage of abstinence. For this purpose, clinical and immunological studies were conducted in 80 patients who use opioid drugs. The duration of the disease ranged from 0.5-19 years. Of these, the disease duration is up to 3 years – 28 patients (group I), and over 3 years – 52 patients (group II). The number of subjects in the control group was n = 50. Authors carried out the assessment of the mental, narcological, somatic, and neurological status. In addition, they have studied the general clinical, biochemical and immunological parameters As a result of this study, it was found, that patients of group I had more pronounced T-lymphocytopenia. A persistent increase in the value of serum IgM was revealed both in the dynamics of abstinence and depending on the duration of the disease, which may indicate a strain on the humoral link of immunity in opium addiction. In addition, as the duration of chronic narcotization increases, there is a tendency to increase the relative number of B-lymphocytes. Thus, at the patients with opium addiction in a state of abstinence develop T-lymphocytopenia. Moreover, with an increase in the duration of the disease, an increase in the level of IgM by 2-2.6 times. The revealed changes in the immunological reactivity of the organism suggest the need to include immunocorrective therapy in the complex of therapeutic measures for opium addiction. 

1. Chechet E.A., Isaikin A.I., Chernenko O.A., Yakhno N.N., Savushkina I.Yu. Chronic inflammatory demyelinating polyradiculopathy and moderate cognitive impairment in a patient suffering from heroin addiction, infected with HIV and the hepatitis C virus. Neurological journal, 2014, Vol. 19, no. 2, pp. 38-46. (In Russ.)

2. Cossarizza A., Chang H.D. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur. J. Immunol., 2019, Vol. 49, no. 10, pp. 1457-1973.

3. Khasina M.A., Molochnikov V.O., Makhachkeeva T.A., Khasina M.Yu. Bioelements in the correction of dysmetabolic disorders in drug addicts. Pacific Medical Journal, 2015, Vol. 1, pp. 48-50. (In Russ.)

4. Kovalev I.A., Sharkova V.A. Clinical and immunological features of opium addiction. Modern Problems of Science and Education, 2016, no. 6. (In Russ.) Available at: https://www.science-education.ru/ru/article/view?id=25622.

5. Litvintsev B.S. Damage to the nervous system in drug addiction: features of symptoms and neurological complications. Bulletin of the Russian Military Medical Academy, 2015, Vol. 1, no. 49, pp. 95-100. (In Russ.)

6. Nevidimova T.I., Vetlugina T.P., Batukhtina E.I., Savochkina D.N., Naydenova N.N., Nikitina V.B., Lobacheva O.A., Menyavtseva T.A., Ivanova S A.A., Bokhan N.A. Features of cytokine production in addiction diseases. International Journal of Applied and Basic Research, 2015, Vol. 1, no. 1, pp. 49-51. (In Russ.)

7. Shatyrko M.A., Reshetnikov I.V., Golodny S.V., Mingazov A.Kh., Kozochkin D.A., Izarovsky B.V., Tseilikman V.E. Features of changes in the immunogram and indicators of free radical oxidation of blood plasma in HIV-infected heroin addicts. Kazan Medical Journal, 2015, Vol. 96, no. 5, pp. 772-775. (In Russ.)

8. Tsygan V.N., Akperov E.K., Vostrikov V.V., Shabanov P.D. Immune dysfunctions in drug addicts and methods of their correction. Reviews on Clinical Pharmacology and Drug Therapy, 2007, Vol. 5, no. 4, pp. 2-81. (In Russ.)